Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001434647-26-000068
Filing Date
2026-08-05
Accepted
2026-08-05 17:19:00
Documents
79
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zvra-20260630.htm   iXBRL 10-Q 1219609
2 EX-10.1 zvra-20260630xex101.htm EX-10.1 11690
3 EX-31.1 zvra-20260630xex311.htm EX-31.1 9999
4 EX-31.2 zvra-20260630xex312.htm EX-31.2 9975
5 EX-32.1 zvra-20260630xex321.htm EX-32.1 5644
6 EX-32.2 zvra-20260630xex322.htm EX-32.2 5626
  Complete submission text file 0001434647-26-000068.txt   7378922

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zvra-20260630.xsd EX-101.SCH 54186
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zvra-20260630_cal.xml EX-101.CAL 89548
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zvra-20260630_def.xml EX-101.DEF 202802
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zvra-20260630_lab.xml EX-101.LAB 667867
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zvra-20260630_pre.xml EX-101.PRE 455668
83 EXTRACTED XBRL INSTANCE DOCUMENT zvra-20260630_htm.xml XML 992021
Mailing Address 101 FEDERAL STREET BOSTON MA 02110
Business Address 101 FEDERAL STREET BOSTON MA 02110 (888) 958-1253
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 261244882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)